Cinnapoietin® is a clear, colourless solution for injection under the skin (subcutaneously) or into a vein (intravenously). It contains a hormone called epoetin beta, which stimulates the production of red blood cells. Epoetin beta is produced by a specialized genetic technology and works in exactly the same way as the natural hormone erythropoietin.Treatment of anemia associated with chronic kidney disease (CKD) in patients on dialysis and symptomatic patients not yet undergoing dialysis.
Increase the yield of autologous blood from patients in a pre-donation program initiated to avoid the use of homologous blood.
Prevention of anemia of prematurity in infants with a birth weight of 750 g to 1500 g and a gestational age of less than 34 weeks.
Treatment of anemia and reduction of transfusion requirements in patients with non-myeloid malignancies, where anemia develops as a result of concomitantly administered chemotherapy.
